Anti-Human TNFA Recombinant Antibody(Certolizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human TNFA Recombinant Antibody(Certolizumab)

Anti-Human TNFA Recombinant Antibody(Certolizumab)

产品编号

YR1612

别名

科研级 Certolizumab ( 赛妥珠单抗 ), Anti-TNFA Recombinant Antibody, Research Grade Certolizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Catalog Number	YR1612
Alias	科研级 Certolizumab ( 赛妥珠单抗 ), Anti-TNFA Recombinant Antibody, Research Grade Certolizumab
Size	1mg, 5mg
Molecular Name	Certolizumab
Molecular Weight	150 kDa
Target	TNFA[Homo sapiens]
Host	Mouse
Antibody Isotype	Fab-IgG1
Clonity	Monoclonal
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Certolizumab pegol, sold under the brand name Cimzia, is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB.
Remarks	This product is for research use only.

推荐产品

400-621-6806
18630936064（微信同号）
周一至周五 8:30-18:00
0